104 related articles for article (PubMed ID: 1712760)
1. Differential expression of two lck transcripts directed from the distinct promoters in HTLV-I+ and HTLV-I- T-cells.
Nakamura K; Koga Y; Yoshida H; Kimura G; Nomoto K
Int J Cancer; 1991 Jul; 48(5):789-93. PubMed ID: 1712760
[TBL] [Abstract][Full Text] [Related]
2. Absence of transcription of lck (lymphocyte specific protein tyrosine kinase) message in IL-2-independent, HTLV-I-transformed T cell lines.
Koga Y; Oh-Hori N; Sato H; Yamamoto N; Kimura G; Nomoto K
J Immunol; 1989 Jun; 142(12):4493-9. PubMed ID: 2786034
[TBL] [Abstract][Full Text] [Related]
3. Human T-cell leukemia virus type-I-infected T-cell lines scarcely produce p56lck, whether or not they express lck mRNA.
Oh-Hori N; Koga Y; Yoshida H; Morita M; Kimura G; Nomoto K
Int J Cancer; 1990 Aug; 46(2):315-9. PubMed ID: 2384277
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of two classes of lck transcripts upon phorbol ester treatment of human leukemic T cells.
Leung S; Miyamoto NG
J Cell Physiol; 1991 Sep; 148(3):344-52. PubMed ID: 1918168
[TBL] [Abstract][Full Text] [Related]
5. lck suppresses gene expression from various promoters including human T-cell leukemia virus type I promoter.
Ohta M; Morita T; Shimotohno K
Jpn J Cancer Res; 1990 May; 81(5):440-4. PubMed ID: 2116390
[TBL] [Abstract][Full Text] [Related]
6. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.
Mills GB; Arima N; May C; Hill M; Schmandt R; Li J; Miyamoto NG; Greene WC
Int Immunol; 1992 Nov; 4(11):1233-43. PubMed ID: 1472476
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of p60lck in HTLV-I-transformed T cell lines detected by an anti-lck monoclonal antibody, MOL 171.
Moroi Y; Koga Y; Nakamura K; Ohtsu M; Kimura G; Nomoto K
Jpn J Cancer Res; 1991 Aug; 82(8):909-15. PubMed ID: 1910028
[TBL] [Abstract][Full Text] [Related]
8. Transrepression of lck gene expression by human T-cell leukemia virus type 1-encoded p40tax.
Lemasson I; Robert-Hebmann V; Hamaia S; Duc Dodon M; Gazzolo L; Devaux C
J Virol; 1997 Mar; 71(3):1975-83. PubMed ID: 9032329
[TBL] [Abstract][Full Text] [Related]
9. IL-2 independent transformation of a unique human T cell line, TY8-3, and its subclones by HTLV-I and -II.
Yoshida T; Miyagawa E; Yamaguchi K; Kobayashi S; Takahashi Y; Yamashita A; Miura H; Itoyama Y; Yamamoto N
Int J Cancer; 2001 Jan; 91(1):99-108. PubMed ID: 11149427
[TBL] [Abstract][Full Text] [Related]
10. Structure of the two promoters of the human lck gene: differential accumulation of two classes of lck transcripts in T cells.
Takadera T; Leung S; Gernone A; Koga Y; Takihara Y; Miyamoto NG; Mak TW
Mol Cell Biol; 1989 May; 9(5):2173-80. PubMed ID: 2787474
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
Adler HT; Sefton BM
Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of lck by retrovirus promoter insertion between two lymphoid-specific promoters.
Adler HT; Reynolds PJ; Kelley CM; Sefton BM
J Virol; 1988 Nov; 62(11):4113-22. PubMed ID: 2845126
[TBL] [Abstract][Full Text] [Related]
13. Two lck transcripts containing different 5' untranslated regions are present in T cells.
Voronova AF; Adler HT; Sefton BM
Mol Cell Biol; 1987 Dec; 7(12):4407-13. PubMed ID: 3501824
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2-dependent but not independent T-cell lines infected with human T-cell leukemia virus type 1 selectively express CD45RO, a marker for persistent infection in vivo.
Moro H; Iwai K; Mori N; Watanabe M; Fukushi M; Oie M; Arai M; Tanaka Y; Miyawaki T; Gejyo F; Arakawa M; Fujii M
Virus Genes; 2001 Dec; 23(3):263-71. PubMed ID: 11778694
[TBL] [Abstract][Full Text] [Related]
15. Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression.
Lin HC; Hickey M; Hsu L; Medina D; Rabson AB
Virology; 2005 Aug; 339(1):1-11. PubMed ID: 15964046
[TBL] [Abstract][Full Text] [Related]
16. [Development of thymic tumor in HTLV-I transgenic rats under control of a lymphoid tissue specific promoter].
Kikuchi K
Hokkaido Igaku Zasshi; 1997 Sep; 72(5):545-64. PubMed ID: 9363470
[TBL] [Abstract][Full Text] [Related]
17. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells.
Xu X; Kang SH; Heidenreich O; Okerholm M; O'Shea JJ; Nerenberg MI
J Clin Invest; 1995 Sep; 96(3):1548-55. PubMed ID: 7657825
[TBL] [Abstract][Full Text] [Related]
19. Selective expression of alternative lck mRNAs in human malignant cell lines.
Sartor O; Gregory FS; Templeton NS; Pawar S; Perlmutter RM; Rosen N
Mol Cell Biol; 1989 Jul; 9(7):2983-8. PubMed ID: 2779553
[TBL] [Abstract][Full Text] [Related]
20. Changes in the relative abundance of type I and type II lck mRNA transcripts suggest differential promoter usage during T-cell development.
Reynolds PJ; Lesley J; Trotter J; Schulte R; Hyman R; Sefton BM
Mol Cell Biol; 1990 Aug; 10(8):4266-70. PubMed ID: 2115123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
